Fouad Namouni, PRESIDENT, R & D at Blueprint Medicines Corp (BPMC), sold 2,094 shares at $56.19 ($118K) on 2022-03-07, disclosed to the SEC on 2022-03-08.
Open-market sale of $118k BPMC by PRESIDENT, R & D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.19 | 1,047 | $59K | 50.0% |
| 2 | $56.19 | 1,047 | $59K | 50.0% |
| Total | $56.19 avg | 2,094 | $118K | 100% |
| Filing → |
| BPMC | SELL | 2024-03-11 | $794K | — | Filing → |
| BPMC | SELL | 2023-10-05 | $362K | — | Filing → |
| BPMC | SELL | 2023-03-08 | $175K | — | Filing → |